Position in WVE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,250,000
-$159,113,037 QoQ
Shares Held
1,000,000
-89.8% QoQ
Ownership
0.507%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WVE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in WVE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,250,000 | 1,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $166,363,037 | 9,786,061 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $106,636,178 | 14,567,784 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $97,607,250 | 15,016,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $101,133,320 | 12,516,500 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $119,025,426 | 9,622,104 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $79,567,478 | 9,703,351 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $26,735,017 | 5,357,719 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $32,092,570 | 5,201,389 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $30,238,036 | 5,987,730 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $21,779,447 | 3,787,730 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,812,828 | 4,618,909 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $19,999,875 | 4,618,909 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $38,688,188 | 5,526,884 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,059,014 | 1,401,389 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,928,208 | 2,747,141 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $900,000 | 450,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,413,000 | 450,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,960,000 | 400,000 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||